Previous 10 | Next 10 |
Trace Analytics Inc. is a leading scalable analytics cannabis/cannabinoid laboratory poised to meet the demands for mandated regulatory cannabis/cannabinoid testing WSDA contracted Trace Analytics for the purpose of doing cannabinoid profiling for the State's industrial hemp program ...
Phoenix, Arizona--(Newsfile Corp. - December 10, 2019) - The Stock Day Podcast welcomed Applied BioSciences Corp. (OTCQB: APPB) ("the Company"), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic therapeutics/biopharmaceuticals ...
BioPharma division is focused on the development and commercialization of novel therapeutics that target the endocannabinoid system (ECS) - BioPharma Division focus unlocks opportunities for non-dilutive capital to fund high-value pipeline - Company seeking to spin-off ...
Phoenix, Arizona--(Newsfile Corp. - November 19, 2019) - The Stock Day Podcast Host Everett Jolly welcomed Dr. Ray Urbanski, CEO of Applied BioSciences Corp. (OTCQB: APPB) ("the Company"), a vertically integrated company focused on the development and commercialization of novel, science-driven...
Successfully building BioPharma pipeline in high-value indications Company plans to advance IND-cleared program into a Phase 1 study in a metabolic disease indication in early 2020 Strategic corporate shift to fully focus on BioPharma Division unlocks opportunities for non-dilutive...
BEVERLY HILLS, CA / ACCESSWIRE / October 24, 2019 / Applied Products ("Applied" or the "Company"), a division of Applied BioSciences Corp. (OTCQB:APPB) and Pond Technologies Holdings Inc. ("Pond") (TSX.V:POND), announced today that Pond Naturals , Pond's wholly owned subsidiary, has...
Dr. Reggio brings over 30 years of active research in the endocannabinoid field with support from the National Institute on Drug Abuse BEVERLY HILLS, CA / ACCESSWIRE / October 10, 2019 / Applied BioSciences Corp. (OTCQB:APPB) ("Applied" or the "Company"), today announced the appointme...
Established life sciences executive with extensive equity capital markets, operational, scientific and business acumen BEVERLY HILLS, CA / ACCESSWIRE / October 7, 2019 / Applied BioSciences Corp. (OTCQB:APPB) ("Applied" or the "Company"), is a company focused on the development of s...
Phoenix, Arizona--(Newsfile Corp. - October 1, 2019) - The Stock Day Podcast welcomed Applied BioSciences Corp. (OTCQB: APPB) ("the Company") CEO, Raymond Urbanski, M.D. for an interview with Stock Day host, Everett Jolly. During the interview, Dr. Urbanski discussed the Company's progress wit...
Leading endocrinology and metabolism academic expert with research focus in pathophysiology and treatment of obesity and type 2 diabetes Robust business development initiative to build biopharmaceuticals pipeline underway with expectation to announce at least one in-licensing agree...
News, Short Squeeze, Breakout and More Instantly...
Applied BioSciences Corp Company Name:
APPB Stock Symbol:
OTCMKTS Market:
Los Angeles, CA, April 27, 2020 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (the “Company”; OTCQB: APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/biopharmaceuticals that tar...
Los Angeles, CA, April 24, 2020 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (the “Company”; OTCQB: APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/biopharmaceuticals that tar...
LOS ANGELES, CA / ACCESSWIRE / March 25, 2020 / Applied BioSciences Corp. (OTCQB:APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to ...